MedPath

Analgesic Efficacy of Adding SCB With Low Concentration Bupivacaine Combined With Dexamethasone on Pain After TKA

Phase 4
Conditions
Sciatic Nerve Block
Adductor Canal Block
Total Knee Arthroplasty
Interventions
Registration Number
NCT03486548
Lead Sponsor
Mahidol University
Brief Summary

This study evaluate the efficacy of adding popliteal sciatic nerve block with low concentration bupivacaine and dexamethasone to abductor canal block for total knee arthroplasty in patient with NSAIDs prescribing precaution. Half of participants will receive popliteal sciatic nerve block, abductor canal block and periarticular injection, while the other half will receive a sham block, abductor canal block and periarticular injection.

Detailed Description

After informed and consent, all patients will be devided into two groups, Sciatic group (group S) and Controlled group (group C). All patients will receive adductor canal block, then patients in group S will receive Sciatic nerve block with low concentration bupivacaine and dexamethasone while partients in group C will receive sham block. All patient will receive spinal anesthesia and intraoperative periarticular injection.

Postoperative pain score, muscle strength, total morphine consumption and adverse events will be record in case record form.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • patient scheduled for single total knee arthroplasty
  • patient with NSAIDs prescribing precautions such as history of NSAIDs allergy, Chronic kidney disease (GFR< 50 ml/min), history of ischemic heart disease or cerebrovascular disease
Read More
Exclusion Criteria
  • patient refusal
  • body weight less than 45 kg
  • history of allergy to bupivacaine or dexamethasone
  • uncontrolled diabetes mellitus
  • contraindicated for spinal block, adductor canal block or sciatic nerve block
  • inability to assess pain score (cognitive or psychiatric history)
  • patient scheduled for revision TKA
  • preexisting neuropathy or neurological deficit in lower extremity
  • preexisting chronic pain (prolonged use of oral morphine 20 mg/day or equivalent)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
control groupbupivacaine and lidocaineadductor canal block with sham block
sciatic groupbupivacaine and dexamethasoneadductor canal block with popliteal sciatic nerve block
sciatic groupUltrasoundadductor canal block with popliteal sciatic nerve block
control groupUltrasoundadductor canal block with sham block
Primary Outcome Measures
NameTimeMethod
postoperative pain score at restpostoperative 24 hours

postoperative pain score at rest at 24 hour

Secondary Outcome Measures
NameTimeMethod
postoperative pain score at anterior and posterior site of kneepostoperative 24 hours

postoperative pain score at anterior and posterior site of knee at 24 hour

postoperative pain score on 45 degree knee flexion and physical therapypostoperative 24 hours

postoperative pain score on 45 degree knee flexion and physical therapy

level of tibialis anterior muscle weaknesspostoperative 24 hours

level of tibialis anterior muscle weakness in 24 hour

adverse eventspostoperative 24 hours

perioperative adverse events such as LAST, hypotension, nausea and vomitting

total morphine consumption in postoperative 24 hourspostoperative 24 hours

total morphine consumption in postoperative 24 hours

patient satisfactionpostoperative 24 hours

patient satisfaction score

length of hospital stay7 days

length of hospital stay

Trial Locations

Locations (1)

Siriraj Hospital, Mahidol University

🇹🇭

Bangkoknoi, Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath